Highly purified N-acetyl-fl-D-hexosaminidase B from normal urine and urine of a patient with mucolipidosis III was used to determine whether it had undergone any of the alterations associated with this genetic defect. Examination by sodium dodecyl sulphate/ polyacrylamide-gel electrophoresis showed that both the enzyme preparations contained protein components with apparent Mr values of 55 000 and 28 000. 
Like other lysosomal hydrolases, N-acetyl-fl-Dhexosaminidase (EC 3.2.1.30) exists in several molecular forms. The two major forms present in human tissues have been designated N-acetyl-fl-Dhexosaminidase A and B and were originally observed in human spleen (Robinson & Stirling, 1968) . There is general agreement that the structural differences between N-acetyl-fl-D-hexosaminidase A and B reside in their subunit compositions (Srivastava & Beutler, 1974; Beutler et al., 1976; Geiger & Arnon, 1976) . N-Acetyl-fl-D-hexosaminidase A is thought to be composed of two polypeptide chains, a and ,6, and N-acetyl-/3-D-hexosaminidase B of only the chain. In man the a and chains are coded by genes on chromosome 15 and 5 respectively (Gilbert et al., 1975; Solomon et al., 1976) .
In the two related lysosomal storage diseases, mucolipidosis II (1-cell disease) and mucolipidosis III (pseudo-Hurler polydystrophy) a number of acid hydrolases, including N-acetyl-/J-D-hexosaminidase, are affected (Neufeld et al., 1975) . Cultured fibroblasts from patients with mucolipidosis II and mucolipidosis III exhibit multiple lysosomal enzyme activity deficiencies (Leroy et al., 1972; Thomas et al., 1973) with a concomitant increase in the Abbreviations used: SDS, sodium dodecyl sulphate.
activities of several of these enzymes in the culture medium (Wiesmann et al., 1971a) and in extracellular fluids (Wiesmann et al., 197 1b) . The analogous clinical and biochemical characteristics of these disorders indicate a similar molecular aetiology of each disease, mucolipidosis III being the milder form. Genetic studies reveal the existence of several complementation groups within and between each disorder Mueller et al., 1981; Shows et al., 1982) which implies that different mutations may occur to either the same protein or to other proteins in the biosynthetic pathway shared by the lysosomal enzymes.
Recent evidence suggests that the primary mutation in mucolipidosis II and mucolipidosis III is due to a deficiency of N-acetylglucosaminylphosphotransferase activity (Hasilik et al., 1981; Reitman et al., 1981) , an enzyme responsible for the transfer of N-acetylglucosamine 1-phosphate from 5'-diphosphate (UDP)-N-acetylglucosamine to the high-mannose-type oligosaccharide unit(s) of the acid hydrolases. The failure to attach the correct recognition marker on the mucolipidosis II and mucolipidosis III hydrolases subsequently leads to a conversion of their high mannose-type chains to complex type units prior to secretion from the cell (Sly et al., 1979; Kress et al., 1980a; Miller et al., 1981a,b 
Materials and methods
Assay ofN-acetyl-fl-D-hexosaminidase N-Acetyl-13-D-hexosaminidase was assayed by using the fluorogenic substrate 4-methylumbelliferyl-I-acetamido-2-deoxy-/3-D-glucopyranoside (KochLight, Colnbrook, Bucks., U.K.) as described previously (Miller et al., 1981b) . One unit of activity is that amount of enzyme that transforms 1 nmol of substrate/min under these conditions. Protein determination Protein was measured by using the Coomassie Blue dye-binding method of Bradford (1976) with bovine serum albumin (Sigma) as a standard.
Purification ofN-acetyl-/I-D-hexosaminidase B
(1) Initial fractionation. Normal urine was collected from healthy male adults. The mucolipidosis III urine was collected from a single female patient whose clinical and biochemical background have been described elsewhere (Herd et al., 1978) . The urine samples were stored at 40C with 0.02% NaN3 as a preservative. The matcrial precipitating from the urine samples between 0% and 60% saturation with (NH4)2504 was recovered by centrifugation in the 6 x 250 ml angle head rotor of a Sorvall RC-5B centrifuge for 30min at 40C and 17000g. The precipitate was redissolved in 10mM-sodium phosphate buffer, pH6.0, containing 0.02% NaN3 and was dialysed against 10 litres of the same buffer, with three changes, for 4 days at 40C.
(2) Affinity chromatography. The dialysed preparations were applied separately to a column (6 cm x 1.5 cm diam.) of Sepharose-2-acetamido-N-(eaminohexanoyl)-2-deoxy-JJ-D-glucopyranosylamine (kindly provided by Dr. B. Geiger, Weizmann Institute of Science, Rehovot, Israel) which had been previously equilibrated in the above buffer. The column was washed with this buffer until the A280 of the effluent became zero, when it was re-equilibrated with 10mM-sodium citrate buffer, pH4.4, containing 0.02% NaN3. The material that had bound to the column was then eluted with this buffer containing 0.1mM-2-acetamido-2-deoxy-,6-Dgluconolactone (Koch-Light ul) and 1,u1 of choramine-T (2.25 mg/ml) were added. The reaction was allowed to proceed at room temperature for 30s, after which 5,u1 of sodium metabisulphite (10mg/ml) was added. The labelled protein A was recovered by passing the reaction mixture through a Bio-Gel P-2 column (Bio-Rad) packed in a 10ml disposable plastic pipette, equilibrated in phosphate-buffered saline with bovine serum albumin (1 mg/ml) and glycerol (5% v/v).
Peptide maps
Tryptic peptide analysis of the N-acetyl-fl-Dhexosaminidase B components was carried out according to the procedure of Elder et al. (1977) . Incubation with endo-/3-N-acetylglucosaminidase H Enzyme samples (approx. 3,ug of protein) were mixed with 5,u1 of 1% (w/v) SDS. After boiling for Mucolipidosis III N-acetyl-JJ-D-hexosaminidase B 2 min the samples were diluted sufficiently with 50mM-sodium citrate buffer, pH 5.5, in order to reduce the SDS concentration to 0.1% or less, and were then incubated with 5 munits of endo-,B-Nacetylglucosaminidase H (gift from Dr. R. Trimble and Dr. F. Maley, Department of Health, Albany, NY, U.S.A.) at 370C for 18h. The resultant changes in the Mr were detected by polyacrylamide-gel electrophoresis as described previously. Ovalbumin was used as a test for this experimental procedure.
Concanavalin A binding
The binding assay using concanavalin A (Miles) was carried out in 0.1 M-sodium phosphate buffer, pH 5.5, containing human serum albumin (1 mg/ml) (Sigma) and 0.1 mM-CaCl2, -MgCl2 and -MnCl2 using the conditions described previously (Miller etal., 1981b) .
The 'western' blot (Towbin et al., 1979; Burnette, 1981) using rabbit antiserum raised against purified human placental N-acetyl-fl-D-hexosaminidase B (a gift from Dr. B. Geiger) demonstrated the presence of cross-reacting material in both the enzyme preparations (Fig. I b) . Both the 55 000-Mr and the 28 OOO-Mr bands were detected, indicating that the two bands were part of the N-acetyl-,l-Dhexosaminidase B holoenzyme.
Decreases in the affinity of concanavalin A have been reported for several lysosomal hydrolases from patients with mucolipidosis II and mucolipidosis III (Kress & Miller, 1979; Rousson et al., 1979; Hirani & Winchester, 1980; Miller et al., 1981b of N-acetyl-fl-D-hexosaminidase B activity that did not bind to the lectin (normal 30%; mucolipidosis III 38%) suggests that there was no significant change in the affinity of concanavalin A for the mucolipodosis III enzyme.
Chromatography on Ricinus communis lectin
Our previous studies with normal and the patient's urinary N-acetyl-/I-D-hexosaminidase A showed that the mucolipidosis III enzyme has an increased affinity for Ricinus communis lectin (Hirani et al., 1981) . No appreciable binding was observed when normal N-acetyl-/J-D-hexosaminidase B was chromatographed on the Ricinus communis lectin column (Fig. 3a) . However, a small percentage of the activity (8%) did bind to the column following neuraminidase treatment (Fig. 3a) . When the column no additional binding to the lectin was observed. Approx. 15% of the mucolipidosis III enzyme bound to the column (Fig. 3b) (Fig. 4, lanes 1-4) . The increase in the mobility of the 54 000-Mr band of normal urinary N-acetylfl-D-hexosaminidase A (Fig. 4, lane 7) clearly demonstrates that endo-Jl-N-acetylglucosaminidase H is active under these conditions.
Peptide maps
To determine whether the mutation causes an alteration to the protein structure, the 55000 and 28 OOO-Mr chains were analysed by two-dimensional .:::::.:. (Geiger & Arnon, 1976 Hasilik & Neufeld (1980) , where the Mr-63000 subunit was shown to be the precursor of the processed Mr-29 000 (1l) subunit. Besides N-acetyl-fl-D-hexosaminidase, precursor forms that have higher apparent Mr values than mature enzymes have also been reported for aglucosidase and cathepsin D (Hasilik & Neufeld, 1980) from human fibroblasts and ,3-galactosidase and /l-glucuronidase from mouse macrophages (Skudlarek & Swank, 1981) .
The peptide maps of the Mr 55 000 and Mr 28 000 subunits revealed a large degree of similarity between the normal and mucolipodisis III components (Fig. 5) the corresponding normal enzyme (Hirani et al., 1981) . Decreased binding by this lectin for a number of acid hydrolases from mucolipidosis II and mucolipidosis III patients has also been reported by others (Kress & Miller, 1979; Rousson et al., 1979; Hirani & Winchester, 1980; Kress et al., 1980b; Miller et al., 198 lb) . Chromatography on Ricinus communis lectin showed that whereas none of the normal N-acetyl-,B-D-hexosaminidase B bound to the lectin, a small proportion, 15%, of the mucolipidosis III enzyme did bind. This is in sharp contrast to the significant binding (65%) by the patient's N-acetyl-,6-D-hexosaminidase A to this lectin (Hirani et al., 1981) and to the increased binding by other mucolipidosis II and mucolipidosis III lysosomal hydrolases (Sly et al., 1979; Van Elsen & Leroy, 1979; Miller et al., 1981b) . This aberrant binding to Ricinus communis lectin by mucolipidosis II and mucolipidosis III acid hydrolases is indicative of a conversion of their highmannose chains to the complex type. The lack of any significant binding to this lectin by the patient's N-acetyl-fJ-D-hexosaminidase B suggests that only a few additional galactose residues are present on the enzyme.
Incubation of normal and patient's N-acetyl-JJ-Dhexosaminidase B with endo-,6-N-acetylglucosaminidase H was carried out to test for the presence of high mannose chains. This endoglycosidase hydrolyses di-N-acetylchitobiose linkages in oligosaccharides and glycoproteins (Tarentino & Maley, 1974) and requires a tetrasaccharide structure, Man(al -3)Man(all -.6)Man(fl -4)GIcNAc as its specific glycon (Tai et al., 1977) . It does not act on complex oligosaccharide chains nor on aglycone moieties with Fuc(a1-l6)GlcNAc and Fuc(al-p6)-GlcNAc-Asn (Tarentino & Maley, 1975) It appears that the patient's urinary N-acetyl-,B-D-hexosaminidase A undergoes changes whereby its carbohydrate chains are converted to complex type chains (Kress et al., 1980a; Hirani et al., 1981) .
These changes seem to have occurred as a result of the failure of the recognition marker being transferred to the I-cell acid hydrolases (Hasilik et al., 1981; Reitman et al., 1981) . Thus as a consequence the oligosaccharide chains of the I-cell acid hydrolases are further processed from high mannose chains to complex type and they are then secreted from the cell in a similar manner to other serum Freeze et al., 1979) may be an explanation, since it is now acknowledged that carbohydrate moieties of acid hydrolases play a key role in the recognition of these glycoproteins by specific receptors and their subsequent endocytosis.
